Silvia Holod

Mitochondrial Nitric Oxide Synthase: A Masterpiece of Metabolic Adaptation, Cell Growth, Transformation, and Death

J. Poderoso, P. Finocchietto, S. Holod, 2009, Experimental biology and medicine.

The pan‐caspase inhibitor Emricasan (IDN‐6556) decreases liver injury and fibrosis in a murine model of non‐alcoholic steatohepatitis

G. Gores, F. Barreyro, J. Poderoso, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Abnormal mitochondrial fusion–fission balance contributes to the progression of experimental sepsis

J. Poderoso, P. Finocchietto, S. Holod, 2014, Free radical research.

Defective leptin-AMP-dependent kinase pathway induces nitric oxide release and contributes to mitochondrial dysfunction and obesity in ob/ob mice.

F. Barreyro, J. Poderoso, P. Finocchietto, 2011, Antioxidants & redox signaling.

779 PF-03491390 PAN-CASPASE INHIBITOR DECREASES LIVER INJURY AND FIBROSIS IN A MURINE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS (NASH)

G. Gores, F. Barreyro, P. Finocchietto, 2010 .

Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome

F. Barreyro, J. Poderoso, P. Finocchietto, 2008, PloS one.

The biological significance of mtNOS modulation.

J. Poderoso, P. Finocchietto, S. Holod, 2007, Frontiers in bioscience : a journal and virtual library.

Cardiac-specific overexpression of thioredoxin 1 attenuates mitochondrial and myocardial dysfunction in septic mice.

J. Poderoso, P. Finocchietto, S. Holod, 2016, The international journal of biochemistry & cell biology.